Prestige Consumer Healthcare
288 hedge funds and large institutions have $3.17B invested in Prestige Consumer Healthcare in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 98 increasing their positions, 106 reducing their positions, and 25 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
91% more call options, than puts
Call options by funds: $153K | Put options by funds: $80K
48% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 25
9% more capital invested
Capital invested by funds: $2.92B → $3.17B (+$256M)
3% more funds holding
Funds holding: 279 → 288 (+9)
1.57% more ownership
Funds ownership: 102.81% → 104.38% (+1.6%)
8% less repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 106
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$39.2M |
| 2 |
CAM
Congress Asset Management
Boston,
Massachusetts
|
+$34.5M |
| 3 |
BlackRock
New York
|
+$15.9M |
| 4 |
JP Morgan Chase
New York
|
+$14.1M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$6.68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$10M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.78M |
| 3 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
-$6.92M |
| 4 |
Goldman Sachs
New York
|
-$6.87M |
| 5 |
ZCM
Ziegler Capital Management
Chicago,
Illinois
|
-$6.76M |
PBH Hedge Fund Activity: Q4 2023 in Review
288 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q4 2023, worth a combined $3.17B — up 8.8% from $2.92B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new PBH positions and 25 closed out — a net gain of 12 holders — while 98 added to existing stakes and 106 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $39.2M. The largest seller was Dimensional Fund Advisors, cutting an estimated $10M.
- 288 institutional investors held Prestige Consumer Healthcare (PBH) as of Q4 2023, up from 279 in Q3 2023.
- Funds reported $3.17B of Prestige Consumer Healthcare stock for Q4 2023, up 8.8% quarter-over-quarter.
- 37 funds opened new Prestige Consumer Healthcare positions in Q4 2023 and 25 closed out, a net change of +12 holders.
- The largest Prestige Consumer Healthcare buyer in Q4 2023 was Morgan Stanley, an estimated $39.2M added.
- The largest Prestige Consumer Healthcare seller in Q4 2023 was Dimensional Fund Advisors, an estimated $10M sold.
Based on aggregated 13F filings for Q4 2023.